| |
Media/Press
Researchers from Stanford University
and the Palo Alto Veterans Administration Health Care System Successfully
Complete Initial Pilot Study Focused on Illustrating the Physiologic
Effects of the Cyclic Variations in Altitude Conditioning Process
Larger, more extensive studies are now planned as a result of these
pilot data.
TEMECULA, Calif., February 2, 2007--CVAC Systems, Inc. has been
informed by researchers from Stanford University and the Palo Alto
Veterans Administration Health Care System (VAPAHCS) that the initial
pilot study of the physiologic effects of the Cyclic Variations in
Altitude Conditioning (CVAC TM) process has been successfully completed.
As a result of these pilot data, larger, more extensive studies are
planned.
The prinicipal investigator of the study is Anne
L. Friedlander, PhD., Director of the Exercise Physiology Lab in
the Clinicla Studies Unit and a Consulting Professor for the Program
in Human Biology at Stanford University. Dr. Friedlander reported
that all four athletes studied were able to complete the 6-8-week
protocol and testing with full compliance and no significant adverse
effects. "These data
provide us with the necessary logistical information and observations
to allow us to move forward with a much larger sample size," explained
Dr. Friedlander. While the data remain confidential pending the larger
study and pubication, Dr.Friedlander did report that the preliminary
results appear promising and suggest a strong impact of the CVAC
exposures on the altitude acclimitatization process. "We are
eager to move forward with the larger study, which we expect will
expand on our preliminary findings and begin to identify the underlying
mechanisms of change caused by the CVAC srssions," commented
Dr. Friedlander.
"We are vey pleased with the quality of the research and results
Dr. Friedlander and her staff of researchers at Stanford University
and the VAPAHCS are providing to this fundamental research into the
remarkable physiological effects of the CVAC process. We look forward
to a long and fruitful relationship as we mutually explore the many
potential applications of CVAC technology, which include insulin
resistance, metabolic syndrome and diabetes in addition to exercise
performance enhancement," commented Allen J. Ruszkowski, President
and CEO of CVAC Systems, Inc.
About VAPAHCS
VAPAHCS is a teaching hospital, providing a full range of patient
care services, with state-of-the-art technology as well as eduction
and research. VAPAHCS maintains one of the top three research programs
in the VA. An Affiliation with the Stanford University School of
Medicine provides a rich academic environment including medical
training for physicians in virtually all specialties and subspecialties.
About CVAC Systems, Inc.
CVAC Systems, Inc., headquartered in Temecula, Calif., is privately
funded and is seeking to place CVAC systems at key luminary research
sites for the development of several patent-pending applications
such as performance enhancement, disease prevention, therapy and
advanced health. For these plans, the Company is seeking a first-round
venture/institutional financing.
Copyright © 2007, CVAC Systems, Inc. All
rights reserved. Cyclic Variations in Altitude Conditioning, CVAC
and CVAC logo are trademarks or registered trademarks of CVAC Systems,
Inc. in the United States and/or other Countries. All other trademarks
belong to their respective owners. No affiliation is expressed
or implied herein.
Please note: The information contained within this document is intended
for prospective researchers only, and is not intended for patients
or health care providers. Any references to therapeutic applications
are for discussion and research purposes only.
|
|
 |